Closed
NP39726 Generic and Biosimilar Cancer Medicines
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Value
- £197,026,942
- Published
- 27 Jul 2026
- Deadline
- 26 Aug 2026
- Procedure
- Open procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- UKM
- Notice reference
- 070486-2026
Requirements summary
The Common Services Agency is procuring Generic and Biosimilar Cancer Medicines for NHS Scotland through an open tender procedure, with a total estimated value of GBP 197,026,942. The contract includes multiple lots with specific cancer medicines to be supplied over a twenty-four month period, with the possibility of extension.
Key requirements
- Supply of Generic and Biosimilar Cancer Medicines including Bendamustine, Capecitabine, Cisplatin, Cyclophosphamide, and Cytarabine.
- Single supplier framework agreements for each lot.
- Contract duration of twenty-four months with the option for a twenty-four month extension.
- Mandatory community benefits provision required from bidders.
- Potential suppliers must agree to connect with NHS Scotland's Community Benefits Gateway.
Similar open notices
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- NP43226 Nitric Oxide TherapyThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- NP43226 Nitric Oxide TherapyThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England